—

Medpace Holdings Inc (MEDP) — the peer cohort

As of 2026-10-12 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Medpace Holdings Inc ranks 3 of 10 in its cohort on the Closelooknet composite (63/100) — the cohort is led by Halozyme Therapeutics Inc at 74/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
MEDP Medpace Holdings Inc 63 85 74 28 ok 8.5%
IDXX IDEXX Laboratories Inc 56 28 85 24 bear 32.7%
ILMN Illumina Inc 55 94 76 20 bull 10.1%
ICLR ICON PLC 45 67 32 50 info 19.4%
NTRA Natera Inc 44 93 23 6 bull 8.4%
GH Guardant Health Inc 43 78 17 10 info 14.8%
HALO Halozyme Therapeutics Inc 74 94 94 48 ok 4.9%
DXCM DexCom Inc 66 85 80 35 bull 9.2%
ONC BeiGene, Ltd. 63 76 62 30 info 9%
ARGX argenx NV ADR 62 50 74 29 info 24.3%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-12

Quick answers

Who are Medpace Holdings Inc's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: IDEXX Laboratories Inc (IDXX), Illumina Inc (ILMN), ICON PLC (ICLR), Natera Inc (NTRA), Guardant Health Inc (GH), Halozyme Therapeutics Inc (HALO), DexCom Inc (DXCM), BeiGene, Ltd. (ONC) and others.

How does MEDP score against its peers?

Medpace Holdings Inc's composite reads 63/100, ranking 3 of 10 in its cohort as of 2026-10-12; the cohort's highest composite is Halozyme Therapeutics Inc at 74/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Diagnostics & Research. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.